Breaking News Instant updates and real-time market news.

A

Agilent

$71.44

5.85 (8.92%)

, WMT

Walmart

$111.55

5.3 (4.99%)

09:55
08/15/19
08/15
09:55
08/15/19
09:55

Early notable gainers among liquid option names on August 15th

Notable gainers among liquid option names this morning include Agilent (A) $71.28 +5.70, Wal-Mart (WMT) $111.70 +5.48, NetApp (NTAP) $46.71 +2.00, Macerich (MAC) $30.51 +0.60, and HCP (HCP) $34.12 +0.66.

A

Agilent

$71.44

5.85 (8.92%)

WMT

Walmart

$111.55

5.3 (4.99%)

NTAP

NetApp

$47.59

2.85 (6.37%)

MAC

Macerich

$30.33

0.42 (1.40%)

HCP

HCP

$33.74

0.28 (0.84%)

  • 15

    Aug

  • 12

    Sep

  • 15

    Sep

  • 17

    Sep

  • 18

    Sep

  • 25

    Sep

  • 10

    Oct

  • 13

    Nov

A Agilent
$71.44

5.85 (8.92%)

08/15/19
BARD
08/15/19
NO CHANGE
Target $82
BARD
Outperform
Agilent price target raised to $82 from $79 at Baird
Baird analyst Catherine Schulte raised her price target on Agilent to $82 from $79 following strong Q3 results. The analyst noted its strong growth despite ongoing headwinds from China. She noted management raised guidance but she said there is likely a fair amount of conservatism baked in due to ongoing macro concerns. Schulte reiterated her Outperform rating on Agilent shares.
08/15/19
COWN
08/15/19
NO CHANGE
Target $80
COWN
Outperform
Agilent weakness would be a buying opportunity, says Cowen
Cowen analyst Doug Schenkel noted Agilent posted a solid top and bottom line beat with its Q3 results. The analyst said shares should be bought on any weakness given its above peer average revenue/earnings growth, among the cleanest balance sheets in its group, and its discount valuation. Schenkel reiterated his Outperform rating and $80 price target on Agilent shares.
08/15/19
PIPR
08/15/19
NO CHANGE
Target $86
PIPR
Overweight
Agilent price target raised to $86 from $83 at Piper Jaffray
Piper Jaffray analyst William Quirk raised his price target for Agilent Technologies to $86 from $83 following the company's fiscal Q3 beat and fiscal 2019 guidance increase. After the "hiccup" in Q2 results, Agilent outperformed expectations and deserves a 10% premium to the group since it likely will continue, Quirk tells investors in a research note. He keeps an Overweight rating on Agilent shares.
07/16/19
BOFA
07/16/19
DOWNGRADE
BOFA
Neutral
Waters, Agilent downgraded at BofA/Merrill on China generics risk
As previously reported, BofA/Merrill Lynch analyst Derik De Bruin downgraded Waters (WAT) to Underperform from Neutral and downgraded Agilent (A) to Neutral from Buy, stating that he is more cautious on both following misses in the first calendar quarter and given his channel checks since then. He thinks issues that cropped up for both in China, such as a pause in spending by generic and small molecule drug makers, will likely persist in the near-term, De Bruin told investors. He lowered his price target on Agilent shares to $76 and cut his price target on Waters shares to $199.
WMT Walmart
$111.55

5.3 (4.99%)

07/23/19
LOOP
07/23/19
NO CHANGE
Target $115
LOOP
Hold
Walmart price target raised to $115 from $106 at Loop Capital
Loop Capital analyst Andrew Wolf raised his price target on Walmart to $115, saying the company's recently announced consolidation of the U.S. stores and e-commerce divisions' supply chains and financial management is positive for its continued expansion in omnichannel merchandising. The analyst notes that the perception of this consolidation as a sign of "retrenchment and/or infighting at the senior operating ranks" is mistaken. Wolf is keeping his Hold rating on Walmart however, citing its current valuation.
08/12/19
BARD
08/12/19
NO CHANGE
Target $115
BARD
Outperform
Baird comfortable with Walmart expectations ahead of Q2 results
Baird analyst Peter Benedict said he remains comfortable with Q2 Walmart expectations ahead of its report on Thursday. The analyst believes comp trends will remain solid and although he expects pressure on margins from Flipkart, he sees the company continuing to manage and drive SG&A efficiencies. Benedict reiterated his Outperform rating and $115 price target on Walmart shares.
07/17/19
FBCO
07/17/19
NO CHANGE
Target $195
FBCO
Outperform
Walmart partnership could serve as driver for Advance Auto Parts, says Credit Suisse
Credit Suisse analyst Seth Sigman notes that Advance Auto (AAP) has launched what appears to be the initial phases of its partnership with Walmart (WMT), adding about 5,000 SKUs to the Walmart website. The analyst ultimately believes that, if done right, this could serve as an incremental driver for Advance Auto Parts, benefiting from Walmart's growing online traffic and product offering. That said, more important for the stock in short term will be improving comps after the slow start and weather impact in Q2, along with instilling confidence in the margin outlook, he contends. Sigman has an Outperform rating and $195 price target on Advance Auto Parts' shares.
07/15/19
CHLM
07/15/19
NO CHANGE
CHLM
Sell
PetMed CEO amendment hints at exploration of alternatives, says Craig-Hallum
Craig-Hallum analyst Kevin Ellich noted that PetMed Express (PETS) filed an 8K after the close on Friday to disclose that it amended CEO Mendo Akdag's employment agreement to add the language "for Good Reason" to the "Change in Control" section. He reads this change as a hint that an exploration of strategic alternatives could be upcoming, though he doesn't think there is anything imminent in the works. The analyst, who suspects there is further downside to Street estimates for PetMed given increased competition from Chewy (CHWY), Walmart (WMT), Petco and other online retailers, keeps a Sell rating on PetMed shares.
NTAP NetApp
$47.59

2.85 (6.37%)

08/15/19
RBCM
08/15/19
NO CHANGE
Target $53
RBCM
Outperform
Cisco price target lowered to $53 from $64 at RBC Capital
RBC Capital analyst Mitch Steves lowered his price target on Cisco (CSCO) to $53 after its "disappointing" Q1 guidance driven by the slowing macro environment and weakness in China revenues. Coupled with yesterday's weaker results from Netapp (NTAP), the analyst believes that the overall IT spending environment is slowing relative to consensus expectations, even though he still sees Cisco as a "better defensive name to own" within the hardware and networking sector. Steves is keeping his Outperform rating on the stock longer term based on its market-leading 50% share in network equipment and its ability to weather the current enterprise spending decline.
08/15/19
COWN
08/15/19
NO CHANGE
Target $40
COWN
Underperform
NetApp price target lowered to $40 from $53 at Cowen
Cowen analyst Karl Ackerman lowered his price target on NetApp to $40 from $53 citing a downturn in storage spending which the analyst believes will impact all providers. He noted sales and cost action plans are already in place but he will await stabilization before becoming more constructive on the shares. Ackerman maintained his Underperform rating on NetApp shares.
08/14/19
SRCH
08/14/19
DOWNGRADE
SRCH
Hold
NetApp downgraded to Hold from Buy at Summit Insights
08/15/19
LOOP
08/15/19
NO CHANGE
Target $60
LOOP
Buy
NetApp remains 'structural organic revenue grower', says Loop Capital
Loop Capital analyst Ananda Baruah kept his Buy rating and $60 price target on NetApp, saying its final Q1 earnings were "slightly better" than the negative pre-announcement for the quarter released earlier this month and the discussions featured "net positive" context. The analyst notes that the management offered greater detail about its plans to address the "exaggerated" revenue miss, adding that he continues to view the company as a "structural 5%-10% organic revenue grower." Once NetApp returns to mid-single-digit revenue growth, Baruah contends that the stock should trade at a forward earnings multiple between 13- and 15-times vs. its current valuation of 9.9-times.
MAC Macerich
$30.33

0.42 (1.40%)

02/08/19
WELS
02/08/19
DOWNGRADE
WELS
Market Perform
Macerich downgraded to Market Perform from Outperform at Wells Fargo
06/20/19
MSCO
06/20/19
NO CHANGE
Target $30
MSCO
Underweight
Macerich price target lowered to $30 from $45 at Morgan Stanley
Morgan Stanley analyst Richard Hill said he sees cash flow headwinds accelerating at Macerich (MAC) and believes the market underappreciates its deterioration in free cash flow. The analyst, who projects a $150M-$200M cash shortfall every year after payment of the dividend, lowered his price target on Macerich shares to $30 from $45 and keeps an Underweight rating on the stock. He also lowered his price target on Taubman Centers (TCO) to $45 from $50 and cut his price target for Simon Property (SPG) to $170 from $180 to reflect the challenging retail environment. He has Equal Weight ratings on Taubman and Simon shares.
02/08/19
WELS
02/08/19
DOWNGRADE
Target $43
WELS
Macerich downgraded to Market Perform from Outperform at Wells Fargo
Wells Fargo analyst Jeffrey Donnelly downgraded Macerich to Market Perform from Outperform and lowered his price target to $43 from $65.50. In a research note to investors, Donnelly says he is unable to see an internal catalyst to drive shareholder value and believes Macerich will continue to face outsized capital expenditures for anchor re-tenanting over the next 2-3 years, but 2019 guidance implies cash flow from operations may not fully cover the growing capital needs as well as the common dividend. He adds that he is concerned that with low earnings growth and retained cash flows, there is little internally-generated capital on hand in the event capital needs in the next 2-3 years exceed incremental mortgage refinancing proceeds.
02/08/19
WELS
02/08/19
NO CHANGE
WELS
Wells downgrades Regional Mall REIT sector to Market Weight from Overweight
Wells Fargo analyst Jeffrey Donnelly reduced his rating on the Regional Mall REIT sector to Market Weight from Overweight. The ongoing "revenue disruption" from small-shop and anchor turnover combined with the anchor redevelopment initiatives will be a persistent source of earnings pressure in 2019 and 2020, Donnelly tells investors in a research note. Amid "low and decelerating" core earnings growth relative to other property types, the analyst believes "all but the very best capitalized companies may continue to trade as value ideas." He views Simon Property (SPG) as the dominant global player due to its "strong liquidity, robust balance sheet capacity, high-quality assets, and the depth of personnel capable of undertaking extensive redevelopment programs." Donnelly this morning also downgraded Macerich (MAC) to Market Perform from Outperform and kept an Underperform rating on CBL & Associates (CBL).
HCP HCP
$33.74

0.28 (0.84%)

06/13/19
06/13/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Delphi Technologies (DLPH) upgraded to Buy from Neutral at Goldman Sachs with analyst David Tamberrino saying new CEO Rick Dauch's more operationally focused initiatives should drive "idiosyncratic" margin and free cash flow expansion into 2020. 2. Williams-Sonoma (WSM) upgraded to Accumulate from Hold at Gordon Haskett with analyst Chuck Grom saying following the meetings, and based on more upbeat than expected results from peer RH (RH), he has a higher degree of confidence about both the company's near-term results and its long-term options. 3. Concert Pharmaceuticals (CNCE) upgraded to Buy from Neutral at Janney Montgomery Scott with analyst Esther Hong saying CTP-692 broadens Concert 's clinical pipeline. 4. CenterPoint Energy (CNP) upgraded to Buy on valuation at BofA/Merrill with analyst Julien Dumoulin-Smith citing "compelling" valuation. 5. HCP (HCP) upgraded to Outperform from Market Perform at Raymond James with analyst Jonathan Hughes citing relative valuation and size, development contributions visibility, and accelerating same-store NOI growth. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/13/19
RAJA
06/13/19
DOWNGRADE
RAJA
Market Perform
Welltower downgraded to Market Perform on relative valuation at Raymond James
Raymond James analyst Jonathan Hughes downgraded Welltower (WELL) to Market Perform from Outperform citing relative valuation. The analyst, who upgraded HCP (HCP) to Outperform, says the reversal is driven by HCP's more attractive valuation, smaller size that makes external growth more impactful, and greater visibility from development contributions and accelerating same-store NOI growth. Hughes tells investors that while Welltower is arguably best-positioned among all healthcare REITs to capitalize on the"Silver Tsunami" of aging demographics and generate strong earnings, NAV, and dividend growth for shareholders, he thinks a more prudent approach to the stock is now appropriate.
08/13/19
MUFG
08/13/19
NO CHANGE
MUFG
MUFG raises REIT price targets after 'reasonably good' Q2 results
MUFG analyst Karin Ford says the Real Estate Investment Trusts she covers reported "reasonably good" results in Q2. Following the reporting season, the analyst raises her price target for Neutral-rated Alexandria Real Estate (ARE) to $143 from $137, for Overweight-rated Brixmor (BRX) to $22 from $21, for Overweight-rated Camden Property Trust (CPT) to $117 from $112, for Overweight-rated Essex Property Trust (ESS) to $332 from $308, for Overweight-rated HCP (HCP) to $33 from $31, for Neutral-rated LTC Properties (LTC) to $46 from $43, for Overweight-rated Omega Healthcare (OHI) to $42 from $41, for Overweight-rated Realty Income (O) to $80 from $74, for Overweight-rated Welltower (WELL) to $91 from $83, and for Neutral-rated W.P. Carey (WPC) to $83 from $77. Ford also reduced her price target for Neutral-rated Pennsylvania REIT (PEI) to $6 from $7.
06/13/19
RAJA
06/13/19
UPGRADE
RAJA
Outperform
HCP upgraded to Outperform at Raymond James
As previously reported, Raymond James upgraded HCP to Outperform from Market Perform with a $35 price target. Analyst Jonathan Hughes cites relative valuation and size, development contributions visibility, and accelerating same-store NOI growth for the upgrade. Hughes is more constructive on the stability and predictability of HCP's medical office building and life science portfolios and believes share relative underperformance provides an attractive entry point.

TODAY'S FREE FLY STORIES

ALSN

Allison Transmission

$43.06

-0.96 (-2.18%)

15:30
08/23/19
08/23
15:30
08/23/19
15:30
Conference/Events
Allison Transmission management to meet with RBC Capital »

Meeting to be held In…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Aug

15:30
08/23/19
08/23
15:30
08/23/19
15:30
General news
Treasury Action: bond yields have inched up from intraday lows »

Treasury Action: bond…

IWM

iShares Trust Russell 2000 Index Fund

$146.13

-3.92 (-2.61%)

, RUT

Russell 2000 Index

$0.00

(0.00%)

15:22
08/23/19
08/23
15:22
08/23/19
15:22
Technical Analysis
On The Fly: Weekly technical notes for Russell 2000 »

The Russell 2000 (RUT) at…

IWM

iShares Trust Russell 2000 Index Fund

$146.13

-3.92 (-2.61%)

RUT

Russell 2000 Index

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

15:17
08/23/19
08/23
15:17
08/23/19
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

15:16
08/23/19
08/23
15:16
08/23/19
15:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FCAU

Fiat Chrysler

$12.53

-0.24 (-1.88%)

15:15
08/23/19
08/23
15:15
08/23/19
15:15
Options
Fiat Chrysler put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$285.78

-6.58 (-2.25%)

15:12
08/23/19
08/23
15:12
08/23/19
15:12
Technical Analysis
On The Fly: Weekly technical notes for S&P 500 »

At time of writing the…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$285.78

-6.58 (-2.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DDOG

Datadog

$0.00

(0.00%)

15:11
08/23/19
08/23
15:11
08/23/19
15:11
Syndicate
Datadog files S-1 for IPO, seeks to list on Nasdaq with symbol 'DDOG' »

Datadog filed an S-1 with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HIIQ

Health Insurance Innovations

$18.17

-0.87 (-4.57%)

15:05
08/23/19
08/23
15:05
08/23/19
15:05
Options
Health Insurance Innovations call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Sep

  • 20

    Sep

INCY

Incyte

$82.37

-3.2 (-3.74%)

, LLY

Eli Lilly

$110.50

-1.13 (-1.01%)

14:58
08/23/19
08/23
14:58
08/23/19
14:58
Hot Stocks
Eli Lilly, Incyte announce baricitinib meets primary endpoint in Phase 3 trial »

Eli Lilly (LLY) and…

INCY

Incyte

$82.37

-3.2 (-3.74%)

LLY

Eli Lilly

$110.50

-1.13 (-1.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Sep

  • 09

    Sep

  • 16

    Sep

  • 02

    Oct

  • 23

    Oct

EPD

Enterprise Products

$28.35

-0.605 (-2.09%)

14:55
08/23/19
08/23
14:55
08/23/19
14:55
Options
Enterprise Products put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Aug

LGF.A

Lionsgate

$10.52

-0.28 (-2.59%)

, LGF.B

Lionsgate

$10.01

-0.205 (-2.01%)

14:54
08/23/19
08/23
14:54
08/23/19
14:54
On The Fly
Box Office Battle: 'Angel has Fallen' looking to swoop into top spot »

Welcome to "Box Office…

LGF.A

Lionsgate

$10.52

-0.28 (-2.59%)

LGF.B

Lionsgate

$10.01

-0.205 (-2.01%)

SNE

Sony

$53.87

-0.91 (-1.66%)

CMCSA

Comcast

$42.75

-1.01 (-2.31%)

CMCSK

Comcast

$0.00

(0.00%)

T

AT&T

$34.95

-0.44 (-1.24%)

CBS

CBS

$42.02

-1.43 (-3.29%)

DIS

Disney

$133.09

-2.98 (-2.19%)

VIA

Viacom

$27.31

-0.28 (-1.01%)

VIAB

Viacom

$25.01

-0.85 (-3.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Aug

  • 05

    Sep

  • 05

    Sep

  • 10

    Sep

  • 11

    Sep

  • 23

    Oct

  • 27

    Oct

QSR

Restaurant Brands

$76.37

0.94 (1.25%)

14:45
08/23/19
08/23
14:45
08/23/19
14:45
Options
Restaurant Brands call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:45
08/23/19
08/23
14:45
08/23/19
14:45
General news
Fed funds futures surge on the downdraft in stocks »

Fed funds futures surge…

OSW

OneSpaWorld

$15.84

-0.22 (-1.37%)

14:41
08/23/19
08/23
14:41
08/23/19
14:41
Conference/Events
OneSpaWorld management to meet with William Blair »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Aug

  • 28

    Aug

OPRX

OptimizeRx

$15.16

-0.39 (-2.51%)

14:38
08/23/19
08/23
14:38
08/23/19
14:38
Conference/Events
OptimizeRx management to meet with William Blair »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Aug

  • 12

    Sep

APPN

Appian

$60.63

0.29 (0.48%)

14:37
08/23/19
08/23
14:37
08/23/19
14:37
Conference/Events
Appian management to meet with William Blair »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Aug

  • 27

    Aug

ET

Energy Transfer LP

$13.35

-0.31 (-2.27%)

14:35
08/23/19
08/23
14:35
08/23/19
14:35
Options
Energy Transfer put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NKTR

Nektar

$17.04

0.05 (0.29%)

14:25
08/23/19
08/23
14:25
08/23/19
14:25
Options
Nektar call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Aug

14:20
08/23/19
08/23
14:20
08/23/19
14:20
General news
Treasury Action: yields remain sharply lower on a flight to safety »

Treasury Action: yields…

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
08/23/19
08/23
14:17
08/23/19
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SBGI

Sinclair Broadcast

$43.19

-1.24 (-2.79%)

, DIS

Disney

$133.27

-2.8 (-2.06%)

14:16
08/23/19
08/23
14:16
08/23/19
14:16
Periodicals
Sinclair CEO eyes more regional sports network acquisitions, WSJ reports »

Sinclair Broadcast (SBGI)…

SBGI

Sinclair Broadcast

$43.19

-1.24 (-2.79%)

DIS

Disney

$133.27

-2.8 (-2.06%)

T

AT&T

$34.97

-0.425 (-1.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

  • 10

    Sep

  • 11

    Sep

  • 23

    Sep

  • 23

    Oct

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
08/23/19
08/23
14:16
08/23/19
14:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FANG

Diamondback Energy

$95.83

-3.315 (-3.34%)

14:15
08/23/19
08/23
14:15
08/23/19
14:15
Options
Diamondback Energy put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Aug

  • 11

    Sep

14:10
08/23/19
08/23
14:10
08/23/19
14:10
General news
Action Economics Survey results: »

Action Economics Survey…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.